BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10559258)

  • 1. RIP2 is a Raf1-activated mitogen-activated protein kinase kinase.
    Navas TA; Baldwin DT; Stewart TA
    J Biol Chem; 1999 Nov; 274(47):33684-90. PubMed ID: 10559258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
    Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
    J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
    Yan F; Polk DB
    Cancer Res; 2001 Feb; 61(3):963-9. PubMed ID: 11221891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling.
    Müller G; Storz P; Bourteele S; Döppler H; Pfizenmaier K; Mischak H; Philipp A; Kaiser C; Kolch W
    EMBO J; 1998 Feb; 17(3):732-42. PubMed ID: 9450998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.
    Kim J; Yoon MY; Choi SL; Kang I; Kim SS; Kim YS; Choi YK; Ha J
    J Biol Chem; 2001 Jun; 276(22):19102-10. PubMed ID: 11262401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.
    Yeung KC; Rose DW; Dhillon AS; Yaros D; Gustafsson M; Chatterjee D; McFerran B; Wyche J; Kolch W; Sedivy JM
    Mol Cell Biol; 2001 Nov; 21(21):7207-17. PubMed ID: 11585904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
    Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
    J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.
    Sun H; King AJ; Diaz HB; Marshall MS
    Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation.
    Ruefli-Brasse AA; Lee WP; Hurst S; Dixit VM
    J Biol Chem; 2004 Jan; 279(2):1570-4. PubMed ID: 14638696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of Raf by ceramide-activated protein kinase.
    Yao B; Zhang Y; Delikat S; Mathias S; Basu S; Kolesnick R
    Nature; 1995 Nov; 378(6554):307-10. PubMed ID: 7477354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human cystatin A by keratinocytes is positively regulated via the Ras/MEKK1/MKK7/JNK signal transduction pathway but negatively regulated via the Ras/Raf-1/MEK1/ERK pathway.
    Takahashi H; Honma M; Ishida-Yamamoto A; Namikawa K; Kiyama H; Iizuka H
    J Biol Chem; 2001 Sep; 276(39):36632-8. PubMed ID: 11451947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo.
    Xu Be; Wilsbacher JL; Collisson T; Cobb MH
    J Biol Chem; 1999 Nov; 274(48):34029-35. PubMed ID: 10567369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.
    Natoli G; Costanzo A; Moretti F; Fulco M; Balsano C; Levrero M
    J Biol Chem; 1997 Oct; 272(42):26079-82. PubMed ID: 9334169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
    Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
    Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation.
    Lin SL; Le TX; Cowen DS
    Cell Microbiol; 2003 Apr; 5(4):267-75. PubMed ID: 12675684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
    Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
    J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions.
    Sarkar A; Duncan M; Hart J; Hertlein E; Guttridge DC; Wewers MD
    J Immunol; 2006 Apr; 176(8):4979-86. PubMed ID: 16585594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway.
    Coles LC; Shaw PE
    Oncogene; 2002 Mar; 21(14):2236-44. PubMed ID: 11948406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.